IDEXX Laboratories Inc share price logo

IDEXX Laboratories Inc

NASDAQ: IDXX

Large Cap

$562.70

-4.76

(-0.84%)

as on

IDEXX Laboratories Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $554.03
    $570.63
    downward going graph

    1.54%

    Downside

    1.41%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $23.72
    $23.92
    downward going graph

    95.78%

    Downside

    -95.75%

    Upside

    downward going graph

IDEXX Laboratories Inc share price movements today

Previous Close
$567.46
Open
$564.51
Volume
585.8K
Day's Low - High
$554.03 - $570.63
52 Week Low - High
$23.72 - $23.92

IDEXX Laboratories Inc Historical Returns

1 Month Return
-0.37 %
3 Month Return
-11.83 %
1 Year Return
+ 19.45 %
3 Year Return
+ 16.17 %
5 Year Return
+ 7.08 %

IDEXX Laboratories Inc Stock Fundamentals & Key Indicators

Check IDEXX Laboratories Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.2B

EPS (TTM)

14.5093

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.18%

PE Ratio (TTM)

43.28

Industry PE ratio

26.594

PEG Ratio

3.9474

EBITDA

1.5B

Revenue (TTM)

4.3B

Profit Margin

24.62%

Return On Equity TTM

66.20%

IDEXX Laboratories Inc Stock Valuation

Track how IDEXX Laboratories Inc P/E has moved over time to understand its valuation trends.

IDEXX Laboratories Inc in the last 5 years

  • Overview

  • Trends

Lowest (38.09x)

March 31, 2025

Industry (26.59x)

May 5, 2026

Today (43.28x)

May 5, 2026

Highest (79.24x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 43.28x

IDEXX Laboratories Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IDEXX Laboratories Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$45.2B7.08%43.2824.62%
BUY$32.4B-14.13%25.2818.26%
BUY$174.4B0.31%25.7715.15%
BUY$124.0B-31.18%33.8814.89%

Stock Returns calculator for IDEXX Laboratories Inc Stock including INR - Dollar returns

The IDEXX Laboratories Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

IDEXX Laboratories Inc investment value today

Current value as on today

₹1,33,583

Returns

₹33,583

(+33.58%)

Returns from IDEXX Laboratories Inc Stock

₹18,446 (+18.45%)

Dollar Impact

₹15,137 (+15.14%)

Analyst Recommendation on IDEXX Laboratories Inc Stock

Based on 19 analysts

BUY

68.42%

Buy

31.58%

Hold

0.00%

Sell

Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for IDEXX Laboratories Inc. Average target price of $724.5

IDEXX Laboratories Inc Share Price Target

Get share price movements and forecasts by analysts on IDEXX Laboratories Inc.

What analysts predicted

22.33%UPSIDE

Target Price

$724.5

Current Price

$562.7

Analyzed by

19 Analysts

Target

$724.50

IDEXX Laboratories Inc target price $724.5, a slight upside of 22.33% compared to current price of $562.7. According to 19 analysts rating.

IDEXX Laboratories Inc Stock’s Investor Sentiment and Interest

Search interest for IDEXX Laboratories Inc Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:40% versus previous 30 day period

IDEXX Laboratories Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
915
901
964
1,003
975
954
998
1,109
1,105
1,090
Gross Profit
547
526
593
620
596
570
623
694
683
658
Operating Income
275
245
298
263
303
261
316
373
354
315
EBITDA
305
278
334
300
341
298
351
409
392
356
Interest Expense
8
9
7
8
7
7
7
11
10
10
Depreciation
28
29
29
32
34
33
34
35
36
38
Income Before Tax
267
239
295
259
298
256
310
362
344
306
Income Tax Expense
55
45
59
55
66
40
67
68
70
58
Net Income
212
194
235
203
232
216
242
293
274
248
Net Profit Margin
23.18%
21.58%
24.44%
20.26%
23.87%
22.65%
24.31%
26.50%
24.85%
22.76%

IDEXX Laboratories Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,775
1,969
2,213
2,406
2,706
3,215
3,367
3,660
3,897
4,303
Gross Profit
975
1,097
1,241
1,365
1,571
1,889
2,004
2,189
2,378
2,659
Operating Income
350
413
491
552
694
932
898
1,097
1,128
1,360
EBITDA
428
496
574
640
790
1,036
1,010
1,097
1,275
1,468
Interest Expense
28
31
33
30
32
29
38
35
31
38
Depreciation
-
83
83
88
95
104
111
113
129
145
Income Before Tax
321
381
457
522
661
902
859
1,061
1,109
1,324
Income Tax Expense
99
117
80
94
79
157
180
216
221
264
Net Income
222
263
377
427
581
744
679
845
887
1,059
Net Profit Margin
12.51%
13.36%
17.04%
17.77%
21.49%
23.17%
20.17%
23.08%
22.78%
24.62%

IDEXX Laboratories Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
194
235
203
232
216
242
293
274
248
Operating Cash Flow
249
198
248
220
262
237
185
402
352
Investing Cash Flow
-30
-106
-32
-27
-39
-29
-33
-44
-28
Financing Cash Flow
-101
-144
-210
-290
-232
-330
-165
-313
-351
Change in Cash
122
-56
4
-92
-20
-124
0
43
-28

IDEXX Laboratories Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
263
377
427
582
744
679
845
887
1,059
Operating Cash Flow
373
400
459
648
755
542
906
929
1,178
Investing Cash Flow
-138
138
-205
-109
-292
-195
-125
-207
-136
Financing Cash Flow
-208
-597
-286
-248
-697
-370
-441
-878
-1,161
Change in Cash
32
-63
-33
293
-239
-31
341
-165
-108

Mutual Funds that own IDEXX Laboratories Inc Stock

Check out the Mutual Funds with significant holdings in IDEXX Laboratories Inc.

Global Institutional Holdings in IDEXX Laboratories Inc

Funds
Holdings
Fundsmith LLP
2.36%
Amundi
0.84%
Bank of New York Mellon Corp
2.59%
Bank of New York Mellon Corp
2.05%
Northern Trust Corp
1.16%

IDEXX Laboratories Inc News & Key Events

  • img

    Today's Timeline - 04 May

    Mon, 11:11 PM

    -

    IDEXX Laboratories reports an Earnings ESP of +0.77% and a Zacks Rank of 3, with a 15.5% EPS gain expected.

Insights on IDEXX Laboratories Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IDXX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IDXX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IDXX stock has moved down by -0.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    IDEXX Laboratories, Inc. has experienced a decline in net profit for the last three quarters, decreasing from $293.98 million to $248.18 million. This trend reflects an average decrease of 8.1% in net profit per quarter.

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    IDEXX Laboratories, Inc. has experienced a decline in revenue for the last three quarters. The revenue figures decreased from $1.10 billion to $1.09 billion, reflecting an average decrease of 0.9% per quarter.

About IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
OrganisationIDEXX Laboratories Inc
HeadquartersOne IDEXX Drive, Westbrook, ME, United States, 04092
IndustryDiagnostics & Research
CEOMr. Jonathan J. Mazelsky
E-voting on sharesClick here to vote

Key Management of IDEXX Laboratories Inc

Name

Title

Dr. Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Mr. Amit Gupta

Senior VP, Chief Digital & Information Officer

Ms. Sharon E. Underberg J.D.

Executive VP, General Counsel, & Corporate Secretary

Mr. Michael P. Johnson

Executive VP & Chief Human Resources Officer

Mr. Jonathan J. Mazelsky

President, CEO & Director

Mr. Andrew Emerson

Executive VP, CFO & Treasurer

Mr. Michael J. Lane

Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology

Dr. Nimrata Khatra Hunt P.E., Ph.D.

Advisor

Mr. Bob Asmann

Senior Vice President of Global Operations

Ms. Julie Godon

Senior VP & Global Marketing Officer

FAQs

What is IDEXX Laboratories Inc share price today?

IDEXX Laboratories Inc share price today is $562.7 as on at the close of the market. IDEXX Laboratories Inc share today touched a day high of $570.63 and a low of $554.03.

What is the 52 week high and 52 week low for IDEXX Laboratories Inc share?

IDEXX Laboratories Inc share touched a 52 week high of $23.92 on and a 52 week low of $23.72 on . IDEXX Laboratories Inc stock price today i.e. is closed at $562.7,which is -2252.22% down from its 52 week high and 2272.26% up from its 52 week low.

What is IDEXX Laboratories Inc's market capitalisation today?

IDEXX Laboratories Inc market capitalisation is $0.05T as on .

How to invest in IDEXX Laboratories Inc Stock (IDXX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for IDEXX Laboratories Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in IDEXX Laboratories Inc Shares that will get you 0.0027 shares as per IDEXX Laboratories Inc share price of $562.7 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy IDEXX Laboratories Inc Stock (IDXX) from India?

Indian investors can start investing in IDEXX Laboratories Inc (IDXX) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in IDEXX Laboratories Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on IDEXX Laboratories Inc share’s latest price of $562.7 as on May 5, 2026 at 1:29 am IST, you will get 0.0178 shares of IDEXX Laboratories Inc. Learn more about fractional shares .

What are the returns that IDEXX Laboratories Inc has given to Indian investors in the last 5 years?

IDEXX Laboratories Inc stock has given 7.08% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?